Zum Inhalt wechseln
Zum Inhalt wechseln

Übergangsberichte gemäß Anhang XV

Übergangsberichte gemäß Anhang XV

Annex XV transitional reports of existing substance risk assessments and risk reduction strategies developed under Regulation (EEC) No 793/93, where the work was not finalised by 1 June 2008.

 
Substance name CAS number EC number Responsible MS Docs
Tetrachloroethylene 127-18-4 204-825-9 UK

 

Documents
Cover page[PDF ]

Annex XV transitional report [PDF] [RTF]
Styrene 100-42-5 202-851-5 UK

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF] [RTF]

Risk Assessment Report [PDF] [RTF]
Ethylbenzene 100-41-4 202-849-4 DE

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF] [RTF]

Risk Assessment Report [PDF] [RTF]

Risk Reduction Strategy [PDF] [RTF]
Chloroform 67-66-3 200-663-8 FR

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF] [RTF]

Risk Assessment Report Environment [PDF] [RTF]

Risk Assessment Report Human Health [PDF]

- Annex 1 [PDF]
2-ethoxyethanol 110-80-5 203-804-1 DE

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF] [RTF]

Risk Assessment Report [PDF] [RTF]

Risk Reduction Strategy [PDF] [RTF]
Amines, tallow alkyl 61790-33-8 263-125-1

DE

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF] [RTF]

Risk Assessment Report [PDF] [RTF]

Risk Reduction Strategy [PDF] [RTF]
Trisodium nitrilotriacetate 5064-31-3 225-768-6 NL

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF] [RTF]

Risk Assessment Report [PDF] [RTF]

Risk Reduction Strategy [PDF] [RTF]
Tert-butyl hydroperoxide (TBHP) 75-91-2 200-915-7 NL

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF]

Risk Assessment Report Environment [PDF]

Risk Assessment Report Human Health[PDF]

- Test proposal [PDF]

Risk Reduction Strategy [PDF]
Pitch, coal tar, high-temp. 65996-93-2 266-028-2 NL

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF]

- Appendix 1 [PDF]

- Appendix 2 [PDF]

- Appendix 3 [PDF]

- Appendix 4 [PDF]

- Appendix 5 [PDF]

- Appendix 6 [PDF]

Risk Assessment Report Environment [PDF]

- Appendix 1 [PDF]

- Appendix 2 [PDF]

- Appendix 3 [PDF]

- Appendix 4 [PDF]

- Appendix 5 [PDF]

- Appendix 6 [PDF]

- Explanatory Notes [PDF]

- IUCLID Notes [PDF]

Risk Assessment Report Human Health [PDF]

- IUCLID Notes [PDF]

Risk Reduction Strategy [PDF]
4,4'-isopropylidene-diphenol (Bisphenol-A) 80-05-7 201-245-8 UK

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF] [RTF]
Trisodium hexafluoroaluminate (Synthetic) 13775-53-6 237-410-6 DE

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF] [RTF]

Risk Assessment Report [PDF] [RTF]

Risk Reduction Strategy [PDF] [RTF]
Trisodium hexafluoroaluminate (Natural) 15096-52-3 239-148-8 DE

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF] [RTF]

Risk Assessment Report [PDF] [RTF]

Risk Reduction Strategy [PDF] [RTF]
Alkanes, C14-17, chloro (MCCP) 85535-85-9 287-477-0 UK

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF] [RTF]

Risk Assessment Report [PDF] [RTF]
1-methoxypropan-2-ol (PGME) 107-98-2 203-539-1 FR

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF] [RTF]

Risk Assessment Report [PDF] [RTF]
2-methoxy-1-methylethyl acetate (PGMA) 108-65-6 203-603-9 FR

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF] [RTF]

Risk Assessment Report [PDF] [RTF]
Tris(2-chloro-1-methylethyl) phosphate (TCPP) 13674-84-5 237-158-7 IRL/UK

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF] [RTF]

Risk Assessment Report [PDF] [RTF]
Tris[2-chloro-1-(chloromethyl)ethyl] phosphate (TDCP) 13674-87-8 237-159-2 IRL/UK

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF] [RTF]

Risk Assessment Report [PDF] [RTF]
Disodium tetraborate, anhydrous 1330-43-4 215-540-4 AU

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF]
Boric acid, crude natural 10043-35-3 233-139-2 AU

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF]
Boric acid 11113-50-1 234-343-4 AU

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF]
(Z)-octadec-9-enylamine 112-90-3 204-015-5 DE

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF] [RTF]

Risk Assessment Report [PDF] [RTF]

Risk Reduction Strategy [PDF] [RTF]
Octadecylamine 124-30-1 204-695-3 DE

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF] [RTF]

Risk Assessment Report [PDF] [RTF]

Risk Reduction Strategy [PDF] [RTF]
Amines, hydrogenated tallow alkyl 61788-45-2 262-976-6 DE

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF] [RTF]

Risk Assessment Report [PDF] [RTF]

Risk Reduction Strategy [PDF] [RTF]
Amines, coco alkyl 61788-46-3 262-977-1 DE

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF] [RTF]

Risk Assessment Report [PDF] [RTF]

Risk Reduction Strategy [PDF] [RTF]
Diantimony trioxide 1309-64-4 215-175-0 SE

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF] [RTF]

Risk Assessment Report [PDF] [RTF]
Tris(nonylphenyl) phosphite (TNPP) 26523-78-4 247-759-6 FR

 

Documents
Cover page [PDF]

Annex XV transitional report [PDF] [RTF]

Risk Assessment Report Environment [PDF] [RTF]

- Annex 1 [PDF]

- Annex 2 [PDF]

Risk Assessment Report Human Health [PDF] [RTF]

Risk Reduction Strategy [PDF] [RTF]

 


Route: .live1

Damit Sie die Website optimal nutzen können, verwenden wir Cookies.

Weitere Informationen über unsere Verwendung von Cookies.

Die ECHA bietet zahlreiches Online-Material in Ihrer Sprache an, ein Teil dieser Seite liegt jedoch nur auf Englisch vor. Mehr über die Praxis der Mehrsprachigkeit bei der ECHA.
Diese Nachricht nicht mehr anzeigen.